Experts caution over "fast cures" based on stem cells

04/16/2009 | SF Weekly (San Francisco)

Recent developments, including President Barack Obama's decision to lift funding restrictions on embryonic stem cell research, have boosted programs focusing on stem cell treatments. However, some scientists remain cautious about how research in the field should proceed given the lack of understanding and the risks associated with such treatments. In the haste to meet certain expectations, some worry that funding may be prioritized for immediately applicable research aimed at faster cures, leaving little for more revolutionary work.

View Full Article in:

SF Weekly (San Francisco)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC